Advertise on podcast: Biofounders

Biofounders: Fun conversations with unconventional founders, biohackers, CEOs, and investors you haven’t met yet | Follow along on LinkedIn, Twitter, YouTube, and Instagram | Support the podcast with a 5-star rating on Spotify ⭐⭐⭐⭐⭐ In this Biofounders episode: * [0:00 - 1:53] Introduction by Sofia * [2:29] Grace introduces herself * [8:14] Turning a design hobby into a job in biotech branding * [11:21] How branding in biotech has changed in the last decade * [16:08] Common fears around branding and storytelling in biotech founders * [18:48] B2B vs B2C biotech branding fears and needs * [22:35] Bringing dinosaurs to the NYSE for Ginkgo’s IPO * [24:21] How AI has changed our jobs * [29:09] Questions relevant in today’s biotech ecosystem * [34:10] Going from biotech tools to products that people want * [35:30] How do you build a brand when everybody’s doing the same thing? * [38:25] New formats for biotech branding and a secret new project * [41:28] What makes Oscillator unique * [43:38] Making things that don’t suck and branding as a means to make science work * [47:33] Working with Christina Agapakis and finding her own voice * [51:29] Rituals to stay creative Grace is a chemical engineer turned creative director, or as we would both agree, a Biocreative. At Ginkgo Bioworks, she orchestrated branding for the company’s IPO, which was the largest of a biotech startup ever, and she cofounded GROW, a magazine about the societal aspects of biotechnology, which circulated more than 15,000 copies around the world. She was the first scientist to be recognized by Young Guns as one of the top creatives under 30 in the world, and her work has been recognized by the Art Directors Club, Webbys, Society of Publication Designers, and PRINT. In 2022, she started doing freelance work for companies like Bitbiome and Solugen, and last year, she joined forces with Christina Agapakis to start Oscillator, an agency that crafts new stories where biology and technology meet. This episode is definitely for the biocreatives, whether you’re into branding or storytelling, or you’re simply curious to learn how it’s like to work at the intersection of art and science. We talked about why branding can sometimes feel like therapy for scientists, fears of B2B and B2C biotech companies in their storytelling, what questions she would ask if she was leading a biotech magazine today, what biotech is missing these days, new branding formats, and the Oscillator ethos. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

As part of his work in the public sector, Alexander Titus is one of the Commissioners at the United States National Security Commission on Emerging Biotechnology. He previously worked at the DoD as the Head of Biotechnology Strategy, and helped launch PPPs BioMADE and armi. With too many interests to count, Titus was also part of early-stage startups like Colossal Biosciences; he worked at Google’s healthcare and life sciences division, and cofounded Dauntless Ventures and Decycle Bio. We’ve followed each other since he ran the BioXYZ publication in 2020. Today, he writes about the intersection of science, technology, policy, futures, and fiction through The Connected Ideas Project. His first science fiction novel, Synthetic Eden is now available. In this Biofounders episode: 0:00-3:53 Introduction 3:55 Public and private sector in biotech innovation 10:11 Questions the Pentagon asking about biotech during the pandemic 13:13 Building credibility as biotechnologists through different storytelling 17:49 Lessons from Bioeconomy.XYZ, The Connected Ideas Project, and Synthetic Eden 21:05 How to think about genetically engineered human embryos 27:11 Increasing our reliance on AI and robotics-powered biotechnology 32:35 US-China biotechnological race 36:20 Metrics to assess the progress of biotech 40:37 Lessons from the last few years of the biotech industry and analogies to the tech industry 46:09 How Titus personally decides what to work on at a given time Biofounders: fun conversations with unconventional founders, biohackers, CEOs, and investors you haven’t met yet | Follow along on LinkedIn, Twitter, YouTube, and Instagram | Support the podcast with a 5-star rating on Spotify ⭐⭐⭐⭐⭐ This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

In the year 2000, Michael Elowitz and Stanislas Leibler published the first paper on a genetic circuit built in E. coli. A couple of years later, the first mammalian synthetic circuits emerged with work from Fussenegger in human cell lines. Genetic engineers remained blind to plants until the late 2010s, when similar genetic engineering efforts started in the autotrophs. Long time scales, heterogeneous cell types, and high polyploidy are only some of the technical challenges of plant engineering. Meanwhile, plants account for 80% of all biomass on Earth, they are our carbon capture machines by excellence, the original source of most pharmaceuticals in the world, and the basis of all of agriculture. For startups and academic labs alike, the fact that plant (genetic) engineering lags ~15 years behind other organisms means that the ocean is blue, and a green field lies ahead. When engineered, plants can serve as low-cost, natural bioreactors for pharmaceutical and cosmetic ingredients, for textiles and functional food… they can fix more carbon from the air and produce more food and, in some weird cases, they can even be turned into digital data storage devices and metal mining machines. The following is a Biopunk Tour of the Brophy Lab in Stanford, where they are building new genetic engineering tools for plants and their associated microbes, towards a sustainable future. Their PI, Jennifer Brophy, famously built the first logic gates in plants during her postdoc, setting a precedent for the Brophytes 🌱. PhD student Vivian Zhong and Postdoc Alexander Borowsky were kind enough to answer lots of questions about their current work, challenges and opportunities in industrial plant genetic engineering, under- and over-hyped plant biotechnologies, and societal challenges of engineered plants. * 00:00 — Inside the plant incubator * 00:36 — Vivian’s work to overcome random DNA integration * 01:30 — Alex’s work controlling gene expression in plants * 02:10 — The Brophy Lab’s mission * 02:40 — Overhyped plant biotech * 04:00 — Underhyped plant biotech * 07:50 — Why you should consider doing plant genetic engineering * 08:40 — Public Perception & communication about GMOs * 11:30 — Lab Tour: Plant Transformation & Screening * 14:30 — Microscopy: Visualizing edited plant cells * 15:00 — Building gene constructs on Benchling * 16:15 — Bioengineering: for what purpose? * 17:10 — Futuristic plant biotechnologies More Biopunk Tours of companies, research labs, and perhaps whole biotech cities could be possible — If you’re interested in supporting this content as a sponsor, drop me a line via LinkedIn, Twitter, a Substack comment or message, or by replying to this email! This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

Michael Florea is the co-founder and CEO of Olden Labs, an SF-based company developing and shipping AI smart and low cost cages for animal studies. Michael has had a long term vision to advance human longevity since he was a teenager. After his PhD in biology at Harvard Medical School, where he worked on whole body gene delivery systems, he choose to accelerate biotechnology by building Olden Labs. In just one month after launching, they’ve got over 100 labs, companies, and institutions to sign up for their cages. As of February 2025, they’ve shipped close to 40. In this episode, we talk about the state of longevity, the state of the art in animal monitoring, how the Olden Labs smart cage works (watch YouTube video below for that), why animals are still relevant in a world of virtual biology and organoids, how the data they collect can further improve research, and my personal take on longevity. Biofounders: fun conversations with unconventional founders, biohackers, CEOs, and investors you haven’t met yet | Follow along on LinkedIn, Twitter, YouTube, and Instagram | Support the podcast with a 5-star rating on Spotify ⭐⭐⭐⭐⭐ Timestamps 02:18 Upbringing and early interest in biology and longevity as a teen 7:15 PhD work in whole body gene delivery 13:02 State of the art and challenges of animal cages in research 18:40 Design of Olden Labs cages 27:40 Other companies in the space and vision 29:14 Cloud Lab vision for the next 5-10 years 31:58 Why we still need animals despite advancements in organoids and simulations 35:19 Capturing data for biomedical research 37:02 Longevity questions and discussion Subscribe to weekly updates on the latest biotech outside trad pharma and never miss a Biofounders episode! This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

Arye Lipman cofounded Biosphere, a startup building UV-sterilized bioreactors that replace the 1950’s steam reactors to reduce biomanufacturing costs. Previously, he built a network of biotech labs for startups like Minicircle and invested in some of them. Biosphere came out of stealth this year through a USD $8.8 M seed round led by Lowercarbon Capital and VXI Capital, with participation from Founders Fund. Biofounders: fun conversations with unconventional founders, biohackers, CEOs, and investors you haven’t met yet | Follow along on LinkedIn, Twitter, and Instagram | Support the podcast by sharing a rating on Spotify ⭐⭐⭐⭐⭐ In this episode we cover: * Upbringing in the California countryside and falling for biology (0:00 - 2:44) * Early start in biotech as part of the founding team of an antibodies company (2:52 - 03:35) * Why he built a network of biotech labs and why it wasn’t a good business (03:52 - 8:52) * Investing in biotech through Mars Bio (8:52 - 10:26) * Deep dives into the biomanufacturing industry and why sterility is a key constrain in costs (10:27 - 13:41) * Superstition in biotechnology and redesigning the bioreactor from the ground up (13:50 - 15:59) * Scaling up to move the needle (16:02 - 16:45) * How UV sterilization and cleaning compare to steam (16:54 - 18:00) * Testing performance in plastic and other materials (18:12 - 19:00) * Building both biotech software and hardware to generate feedback loops (19:14 - 21:09) * What the DoD is doing with biotech and how Biosphere is working with them (21:26 - 24:28) * Why they’re not too concerned about downstream innovation (24:51 - 26:40) * The Biopunk vision of industrialized photosynthesis and the realistic future of taking over the chemical industry with industrialized biology (26:41 - 29:32) * Especially if you’re young, take the risk. Join a biotech startup or found your own! (30:00 - 31:16) This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

Onye Ahanotu—scientist, artist, scholar, home chef, material architect, and founder of Ikenga Wines, a company reimagining palm wine, a drink with thousands of years of cultural depth in the global south. He previously worked at Harvard’s Wyss Institute for Biologically Inspired Engineering and remains an active board member of the Counter Culture Lab in Oakland. In today’s episode, we talk about: * How his former interdisciplinary experiences shaped Ikenga wines * How palm wine is actually made and supply chain resilience * Balancing traditional with progressive knowledge in the wine industry * Why he was using GPT tech before ChatGPT was launched * Brand positioning and business model for Ikenga * Why he’s choosing to build his brand slow and methodically, as opposed to going the “build fast and break things” route * Challenges approaching foodtech VCs with a truly unconventional product * Owning a small niche vs going for a well tested and huge market (Blue Ocean strategy) Biofounders: fun conversations with unconventional founders, biohackers, CEOs, and investors you haven’t met yet, but definitely should | Follow along on LinkedIn, Twitter, Instagram → You can best support Biofounders by rating us on Spotify ⭐⭐⭐⭐⭐ Timestamps * 00:00–01:58 Intro: BioFounders, Biopunk, and Onye Ahanotu * 02:01–03:50 Interdisciplinary Product & Brand Thinking * 03:51–06:59 Founding Origins & Prior Experience * 7:00–09:00 Challenges of Palm Wine Commercialization * 09:01–12:00 From Biology to Wine Chemistry * 12:01–14:00 Supply Chain Resilience * 14:01–15:30 Sensory Design & Winemaking Philosophy * 15:31–16:55 On Using GPT Before ChatGPT * 17:46–20:22 Brand Positioning & Target Customers * 20:23–21:49 Business Model: DTC, Preorders, Wine Club * 21:50–24:14 Social Media & Brand Expression * 24:15–26:30 Line between engineered and natural wine * 26:33–28:16 Why Not Make Grape Wine? * 28:18–31:14 Climate Change as an Opportunity for Leapfrogging * 31:15–35:09 VC Challenges & Blue Ocean Strategy * 35:10–36:47 Food Trends, Cultural Shifts & Future Bet * 36:48–End Closing Remarks & Founder Advice This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

By day, Nick is a postdoctoral researcher in the group of Ueli Grossniklaus at the University of Zürich. By night, he is a flower engineer and artist on a mission to communicate the beauty of plant science to the public through educational projects… you may recognize him as the guy who genetically engineered Arabidopsis flowers and leaves to have different colors and shapes. In this episode: * Where do you draw the line between art and science? * Can we build flower design LLMs? * Could we engineer interactive, responsive, moving plants? * How can we epigenetically reprogram plants? * What future plant biotech tool would you be the most blown away by? * What are Nick’s next steps in his educational projects? * What are the craziest ideas to make with plant engineering? * How is biology different to other expression media? Follow the Biopunk: * Sofia’s X * Biopunk on X * Sofia’s LinkedIn * Biopunk on LinkedIn Thanks for following the Biopunk! Please share this episode, there will be new ones every week ;) This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

Senseory is a startup creating plants that bring natural, effervescent aromas indoors. This is an interview with Gigi Minsky, the co-founder and CEO. We talk about her previous experience at companies like Ginkgo Bioworks, her business plan for Senseory, working with a plant biohacker, and the product's most important technical specs (what they can say for now). Enjoy my intro on why I think companies Senseory are the future of consumer biotechnology. Thanks to Elliot Roth for kindly providing the space to record and thanks to Gigi for helping me experience the biotech they’re creating :-) This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

Checa el trabajo más reciente de Memo en esta nota. Suscríbete gratis a Biofounders y Biopunk para conectarte al primer mundo de la biotecnología mediante newsletters, videos y podcasts. Sigue a Sofía en Twitter o LinkedIn para platicar sobre startups, biotecnología, o filosofía. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

Episode highlights in 5-min video * MeliBio started as a precision fermentation company yet pivoted towards a plant-based product to avoid remaining as a “garage science project” for too long, without fulfilling their mission. * Darko experienced first-hand the hurdles of building not one but two manufacturing facilities in his previous jobs. He’s now outsourcing that for MeliBio and focusing on building a great team that improves the science and the brand for their customers. * Coming from a place of scarcity of resources, Darko is the only biofounder I’ve heard talk about the importance of using venture capital as a launchpad, which means making the right decisions to reach profitability. PS: HAPPY 4th-year BIRTHDAY, MeliBio 🥳!! Looking forward to trying out Mellody on my pancakes very soon 🍯. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

It’s 5:00AM in Toluca when Sofia Sanchez wakes up to the sound of her Westclox, ready for another day as a business major. She drives to her hometown’s business school, listening to the radio, wondering what her professor’s reaction will be to the 76-page final report she wrote with the help of her beloved IBM Selectric, her worn-out Chartpak stencil, her family’s encyclopedia, and Mexico City’s IBM center for some calculations. She makes a stop at a phone call station to remind her teammate to correct the finger mistake on the cardboard they made about some ultra-innovative “personal computing” devices her uncle in the US once told her about. Not much more is to be said about Sofia Sanchez. April 1st, 2024 was just another day for a normal 20-year-old in a small town in Mexico. Thank Lick it’s April Fool’s! “How do the current and next thing get determined?” was the question that gave birth to this piece. Whether they’d be ideas, beliefs, fonts, or technologies, I’d been deeply curious to understand the nature of trends in our world. I wanted to know if there were principles for steering the world towards a particular direction, and whether I could use those principles to change the way biotechnology changes the world. For the past few weeks, I’ve explored J.C.R Licklider’s visionary mind, Everett Roger’s theory on the Diffusion of Innovations, René Girard’s Theory of Mimetic Desire, and the desires of GenZ influencers on Instagram. This piece is a third batch of thoughts at the intersection of culture and biology, this time focusing on how biology can influence modern culture as much as modern culture influences biology. The Presynbiotech Era The habitants of the terrifying alternate universe I described in the very first paragraph, are firm believers that the future is merely what hasn’t happened yet but eventually will. To them, technology equals destiny and evolution is synonymous with inexorable. What we, in this universe made happen in 30 years, they might start dreaming about in 60. To yours and my own fortune, 5 years prior to the birth of Moore’s Law, Man-computer symbiosis was published by J.C.R Licklider (Lick for us friends). While Moore had made an accurate prediction on how far we could take computers, Lick set a clear vision and agenda for how personal computers and the intergalactic network would become the new medium of creative expression: how tech would change culture. Lick dreamed about everything from Zoom to PayPal, Instagram, and the iPad and he led the development of early versions of them. Slightly paraphrased, one of my absolute favorite passages in the Dream Machine book answers how he did that: Lick knew he couldn’t get it all done in one year or two years or a lifetime. By creating a community of fellow believers, however, he guaranteed that his vision would live on after him. When he arrived at ARPA in 1962, there was nothing more than a handful of uncoordinated efforts scattered across the country. By the time he left in 1964, he had forged those into a nationwide movement with direction, coherence and purpose. By putting most of the money into universities, he supported the rising generation, whose hearts and minds he won and convinced that computer science was an exciting thing to do. In 1988, that community was the one thing that he was willing to take credit for: “I think I found a lot of bright people and got them working in this area”. Of course, we would be doomed too if the world was only full of dreamers like Lick! We need builders like Alan Kay who build them to life and artists like Steve Jobs who steal from them and bring the tech to everyone once it’s cheap enough. Call it lack of vision, bad management or timing, neither Intel nor H&P nor Xerox nor IBM capitalized on their decades of technological advantage over the garage hackers. Yet the garage hackers didn’t invent the tech alone; they more so put the puzzle together once the pieces were there. Dream, build, sell. Today, we are living in the Presynbiotech Era. It is a time before ubiquitous Artificial Intelligence-engineered life, a time before the worlds of silicon and carbon intelligence truly fuse as one. Oddly enough, I have not yet encountered a clear 50-year dream of the social paradigm shifts that we will create through biotechnology. If no one’s even dreaming, how will we arrive at a different future❗❓ Computers have changed the way we think. Synbio will change the way we feel. There will not only be dinosaurs, but UBERs, TikTok marketplaces and AirBnBs. We will have new kinds of enhanced humans of mixed sexes, races and talents, iPlants that act as programmable vending machines where I can buy anything from on the street, an axolotl-turtle hybrid that wakes me up in the morning and cleans my bedroom, and expresso machines that use personalized capsules that keep track of and maintain each one of my biomarkers in place. End of famine, disease, poverty and war too. The fact that we even start thinking of a Pre-synbiotech Era means that we can start dreaming about a Synbiotech one. If you’d been waiting for a call, here you go: I’m calling YOU to share more audacious, truly crazy, dreams of a Synbiotech future, for those who look back on these dreams 50 years hence might as well be living them. And surely, remember: had the world waited for Lick to sell iPads, you would not be reading this either. Dreams matter as much as execution and you truly can learn anything. So if you enjoy building, go for it. Real artists ship. Today’s weirdos are tomorrow’s basics In his Theory on the Diffusion of Innovations, Everett Rogers defines innovation as anything that is perceived as new by someone. He categorizes the adopters of an innovation into 5 main groups, according to influential power, risk aversion and the resulting order in which they adopt: the innovators, early adopters, early majority, late majority, and laggards—A business school all-time favorite. The graph is so good that reading the whole book won’t get you much farther than: 1) it’s early adopters (aka influencers) and not innovators who bring innovations to billions; 2) though anyone can be an influencer, the closer the better; 3) the who matters more than the what. The theory checks as I go back to my latest purchasing and habit decisions. For example, I’d heard about the WHOOP band from Bryan Johnson, Steve from Diary of a CEO, other macro influencers and numerous YouTube ads, but I was only convinced enough to buy it until I interacted closely with a user I could relate to: a young, female, Mexican bioengineer who’d graduated from the same university where I study. Something that Tesla has left clear too, is that innovators and early adopters can absorb the cost of being first. They are not only helping spread the technology by providing feedback and generating revenue but by modeling that desire to the early majority that relies on and admires them. Where Rogers falls short and Girard goes deeper is in the actual dynamics between influencers and followers. What I learned from reading about the Theory of Mimetic Desire is that, in our quest for personal differentiation, we look up to people whom we can relate to, who are looked up to by people like us AND who have something we still lack. The most obvious examples of influencers are early adopters like Bryan Johnson and Steve. The more subtle yet more powerful influencers are people like the bioengineer with the WHOOP who had something I wanted (being perceived as a healthy person) while still being relatable. Lick’s dreams have come to life to such an extent that being an internet influencer is no longer exclusive to elites. The rise of the microinfluencer (shift in the distribution of goods but a paradigm shift of trust from the system towards the individual (which Lick’s visions quite promoted too). I, a GenZ girl, no longer care for what Walmart might put on TV or even YouTube ads but tell me about the 20-second reel of a microinfluencer on her Sunday trip to Walmart and I’ll buy the thing just as I bought the WHOOP. “The thing” only matters to the innovators and the early adopters, the masses only care about who is modeling it. One day you buy the story of Zuck and Thiel dropouts, the next you buy YC’s and PG’s of staying in school. Stupid TikTok trends go viral and waves of Web3, LLM and VR founders come and go. Why, then, wouldn’t we be able to make culturally viral biotechnology once it’s ready? In all non-pharma biotech, I consider myself an early adopter (and aspiring innovator) of ideas. While all opinion leaders are early adopters, however, not all early adopters are opinion leaders. The key to innovations crossing the chasm towards the early majority is in opinion leaders (aka influencers). I think biotech in particular, needs translators: people lying at the intersection of innovators and early adopters. Translators understand the science well enough to SHOW and SELL it to an early majority of niche influencers who will take it to the masses. In the best case, they are founders with amazing products who are also great storytellers. Idea-grown bioeconomies People are freaking making live sales on TikTok, snacks are the new autographs, the young are heavily steering towards lifestyles of running more than drinking and subscribing more than we owning. Sustainability and diversity are on the agenda and actions of major corporations, and social media is the new search engine not only for products but for people starting communities and friendships that are URL-first and IRL-second. Knowing stuff like Moore’s law for DNA gets you to build Ozempic. Knowing where culture is headed (and where it’s not) gets you to design the right thing in the first place so that billions actually use it. It gets to to understand the power of making pilots with [farmers] who are also influencers who can model yo

Majo es actual investigadora en UCSF. Es iGEMer de corazón, ayudó a empezar Compound Foods (alternativa sustentable para el café), y estudió en el TEC de Costa Rica. Me da mucho gusto que podamos compartir contigo sus fascinantes e inspiradoras experiencias! Mis links: * Twitter * LinkedIn * Substack (blog) This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

Entrevista completa en YouTube Mi serie de artículos con GRIDX This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

Evan is a super fun and kind plant synthetic biologist from Berkeley whose work focuses on improving CO2 capture. Even beyond that, Evan is mindful and proactive about making SB safe and accessible to everyone through efforts like spreading this knowledge to people in Kenya! In this family friendly (jargon-free) conversation, we touch on relevant books, the craziest things he’s seen plants do, how he juggles between being a saxophonist and a plant synthetic biologist, how it’s like inside the IGI, and more! Feel free to share with friends and fam! ‘til next one,S🧠fia Last 20 minutes This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe

Li Lu es la CEO de Forma Foods, la primera empresa de carne cultivada en México, que ha reunido a los mejores expertos en ingeniería de tejidos, bioreactores, y ciencia de carne para ofrecer la proteína del futuro a millones de Mexicanos. Con inversión de Saya Bio, comenzaron con un prototipo a base de plantas y están a buscan transicionar pronto a un producto híbrido con células animales, para tener en un futuro carne al 100% como la conocemos hoy. En esta entrevista: * Por qué Li Lu dejó la industria energética y petrolera para cumplir un sueño de niña de crecer carne “en un árbol” * Cómo Saya Bio empezó a reunir al equipo de Forma e invirtieron en ellos * Impresión 3D de células en un laboratorio de investigación del Tec de Monterrey a la carne a base de plantas y futuros híbridos * Cómo conectar con un mercado a través de la creatividad, meticulosidad, y la identidad Mexicana * Las ideas más locas que pueden imaginar, y posiblemente crear, los meat designers * Consejos para futuros fundadores de empresas de biotecnología Episodios similares: * Yadira Tejeda - Cofundadora @ CellAgCanada * Cai Linton - CEO & Cofounder @ Multus Media * Alan Perlstein - CEO @ California Cultured This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe